VOYA Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-66,434
| Closed | -$401K | – | 2711 |
|
|
2019
Q4 | $401K | Buy |
66,434
+10,615
| +19% | +$61.4K | ﹤0.01% | 2012 |
|
|
2019
Q3 | $201K | Hold |
55,819
| – | – | ﹤0.01% | 2242 |
|
|
2019
Q2 | $150K | Hold |
55,819
| – | – | ﹤0.01% | 2373 |
|
|
2019
Q1 | $165K | Hold |
55,819
| – | – | ﹤0.01% | 2321 |
|
|
2018
Q4 | $89K | Hold |
55,819
| – | – | ﹤0.01% | 2425 |
|
|
2018
Q3 | $205K | Hold |
55,819
| – | – | ﹤0.01% | 2323 |
|
|
2018
Q2 | $158K | Hold |
55,819
| – | – | ﹤0.01% | 2430 |
|
|
2018
Q1 | $207K | Hold |
55,819
| – | – | ﹤0.01% | 2298 |
|
|
2017
Q4 | $161K | Hold |
55,819
| – | – | ﹤0.01% | 2407 |
|
|
2017
Q3 | $251K | Hold |
55,819
| – | – | ﹤0.01% | 2265 |
|
|
2017
Q2 | $256K | Buy |
55,819
+6,730
| +14% | +$27.1K | ﹤0.01% | 2262 |
|
|
2017
Q1 | $207K | Hold |
49,089
| – | – | ﹤0.01% | 2259 |
|
|
2016
Q4 | $203K | Hold |
49,089
| – | – | ﹤0.01% | 2290 |
|
|
2016
Q3 | $398 | Hold |
49,089
| – | – | ﹤0.01% | 1874 |
|
|
2016
Q2 | $383K | Hold |
49,089
| – | – | ﹤0.01% | 1871 |
|
|
2016
Q1 | $379K | Hold |
49,089
| – | – | ﹤0.01% | 1868 |
|
|
2015
Q4 | $530K | Hold |
49,089
| – | – | ﹤0.01% | 1673 |
|
|
2015
Q3 | $339K | Sell |
49,089
-6,912
| -12% | -$56.3K | ﹤0.01% | 1968 |
|
|
2015
Q2 | $496K | Hold |
56,001
| – | – | ﹤0.01% | 1941 |
|
|
2015
Q1 | $552K | Hold |
56,001
| – | – | ﹤0.01% | 1856 |
|
|
2014
Q4 | $686K | Sell |
56,001
-4,842
| -8% | -$59.1K | ﹤0.01% | 1708 |
|
|
2014
Q3 | $607K | Sell |
60,843
-5,262
| -8% | -$48.8K | ﹤0.01% | 1772 |
|
|
2014
Q2 | $500K | Sell |
66,105
-22,839
| -26% | -$91.1K | ﹤0.01% | 1987 |
|
|
2014
Q1 | $293K | Hold |
88,944
| – | – | ﹤0.01% | 2341 |
|
|
2013
Q4 | $295K | Buy |
88,944
+27,936
| +46% | +$81.1K | ﹤0.01% | 2323 |
|
|
2013
Q3 | $184K | Hold |
61,008
| – | – | ﹤0.01% | 2509 |
|
|
2013
Q2 | $499K | Buy |
+61,008
| New | +$466K | ﹤0.01% | 1836 |
|
VOYA Investment Management's ACHN Position: Q1 2020 in Review
VOYA Investment Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 66,434 shares — an estimated $401K sold.
VOYA Investment Management first reported a position in ACHN in Q2 2013 and held it in 27 quarters. The position peaked at $686K in Q4 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- VOYA Investment Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- VOYA Investment Management sold 66,434 Achillion Pharmaceuticals shares in Q1 2020, an estimated $401K.
- VOYA Investment Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 27 quarters.
- VOYA Investment Management's Achillion Pharmaceuticals position peaked at $686K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on VOYA Investment Management's 13F filing for Q1 2020, filed 15 May 2020.